Insider purchases 885 shares of AMTB at market price amid price recovery and solid profitability.
An insider at Amerant Bancorp purchased shares at the prevailing market price in an open-market transaction, signaling confidence in the company's direction. The stock is trading well below its year-high but has recovered meaningfully over recent weeks and months, suggesting positive momentum despite remaining in the lower half of its annual trading range. Amerant is a profitable financial institution with solid earnings generation, and the insider's modest yet deliberate purchase occurs at a reasonable valuation multiple relative to the company's earnings power. This buy-in-strength pattern—adding shares as the stock rebounds from weakness—is a constructive signal of insider conviction, though the transaction size is measured rather than aggressive. The timing and price point suggest the insider views current levels as attractive, even as broader market context warrants confirmation through subsequent earnings reports.
Carlos Iafigliola purchased 1,000 shares of AMTB at $21.74; stock up 11.2% over 30 days despite negative full-year earnings.
Iafigliola acquired 1,000 shares at $21.74 on 2026-01-30, bringing holdings to 15,963 shares. The transaction occurs in a mixed backdrop: AMTB trades at $21.70 (current), down 9.4% from its 52-week high of $23.95, but has rebounded 11.2% over the prior 30 days and 29.4% over 90 days. This buy follows a period of substantial price recovery. However, the company's full-year net income was negative, creating a tension between near-term price momentum and underlying profitability. The insider's decision to purchase 1,000 additional shares (a 6.7% increase in holdings) during this recovery period, despite the negative annual earnings backdrop, is observable without attributing motivation.
